Pancreatic Cancer Research

ResearcherOslo University HospitalNo recent work listed

Petter Angell Olsen

Matched on ORCID iD 0000-0001-6976-5472; OpenAlex author ID A5012019176.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
3 (first author 2, last author 0)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper

Papers 3

  1. 5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin. Co-author DOI 10.1186/s13046-017-0662-6↗
  2. Expression profiling of wild type and β-catenin gene disrupted human BxPC-3 pancreatic adenocarcinoma cells. First author DOI 10.1016/j.gdata.2015.04.010↗
  3. Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells. First author DOI 10.1371/journal.pone.0115496↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Kaja Lund · 3 shared papers, 2014–2017
  2. Stefan Johannes Karl Krauss · 3 shared papers, 2014–2017
  3. Pål Kristian Selbo · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.